Literature DB >> 16522869

A quantitative assay for aggrecanase activity.

Horst Will1, Matthias Dettloff, Peter Bendzkô, Peter Sveshnikov.   

Abstract

Aggrecanase activities of ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) proteinases were measured with a recombinant aggrecan fragment and two monoclonal antibodies. Recombinant human aggrecan interglobular domain was first incubated in the presence of ADAMTS enzymes. The aggrecan peptide with the N-terminal sequence ARGSVIL released upon hydrolysis was then quantified in an enzyme-linked immunosorbent assay (ELISA) with an anti-neoepitope antibody specific for the N-terminal ARGSVIL sequence and a second anti-aggrecan peptide antibody. For higher sensitivity of the assay, P1-P5 residues of the aggrecanase site within the aggrecan substrate were changed by in vitro mutagenesis. Specific activities of recombinant truncated ADAMTS1 and ADAMTS4 estimated with authentic aggrecan interglobular domain amounted to 2.4 +/- 0.4 and 21.7 +/- 9.5 nmoles hydrolyzed substrate/min.mg, respectively. The values were 10.3 +/- 5.1 and 151.5 +/- 93.5 nmoles/min.mg for hydrolysis of the modified substrate. The aggrecanase activity assay can be used for (1) kinetic characterization of aggrecanase activities of human and animal ADAMTS, (2) screening of inhibitors for aggrecan hydrolyzing ADAMTS, and (3) estimation of aggrecanase activities in biological samples.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16522869      PMCID: PMC2291753     

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  22 in total

1.  TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).

Authors:  M Kashiwagi; M Tortorella; H Nagase; K Brew
Journal:  J Biol Chem       Date:  2001-01-23       Impact factor: 5.157

2.  Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4.

Authors:  J D Sandy; J Westling; R D Kenagy; M L Iruela-Arispe; C Verscharen; J C Rodriguez-Mazaneque; D R Zimmermann; J M Lemire; J W Fischer; T N Wight; A W Clowes
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

3.  Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member.

Authors:  R T Matthews; S C Gary; C Zerillo; M Pratta; K Solomon; E C Arner; S Hockfield
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

4.  Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4).

Authors:  G Hashimoto; T Aoki; H Nakamura; K Tanzawa; Y Okada
Journal:  FEBS Lett       Date:  2001-04-13       Impact factor: 4.124

Review 5.  Cartilage proteoglycans.

Authors:  C B Knudson; W Knudson
Journal:  Semin Cell Dev Biol       Date:  2001-04       Impact factor: 7.727

6.  Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation.

Authors:  Gui Gao; Jennifer Westling; Vivian P Thompson; Troy D Howell; Paul E Gottschall; John D Sandy
Journal:  J Biol Chem       Date:  2002-01-16       Impact factor: 5.157

7.  Truncation of the amino-terminus of the recombinant aggrecan rAgg1mut leads to reduced cleavage at the aggrecanase site. Efficient aggrecanase catabolism may depend on multiple substrate interactions.

Authors:  C Hörber; F H Büttner; C Kern; G Schmiedeknecht; E Bartnik
Journal:  Matrix Biol       Date:  2000-11       Impact factor: 11.583

8.  Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4).

Authors:  M D Tortorella; M Pratta; R Q Liu; J Austin; O H Ross; I Abbaszade; T Burn; E Arner
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

9.  Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1.

Authors:  Robert P T Somerville; Jean-Michel Longpre; Katherine A Jungers; J Michael Engle; Monique Ross; Stephen Evanko; Thomas N Wight; Richard Leduc; Suneel S Apte
Journal:  J Biol Chem       Date:  2003-01-03       Impact factor: 5.157

Review 10.  Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function.

Authors:  H Watanabe; Y Yamada; K Kimata
Journal:  J Biochem       Date:  1998-10       Impact factor: 3.387

View more
  2 in total

1.  Proteolytic processing causes extensive heterogeneity of tissue matrilin forms.

Authors:  Harald W A Ehlen; Gerhard Sengle; Andreas R Klatt; Anja Talke; Stefan Müller; Mats Paulsson; Raimund Wagener
Journal:  J Biol Chem       Date:  2009-06-16       Impact factor: 5.157

2.  Screening of potential a disintegrin and metalloproteinase with thrombospondin motifs-4 inhibitors using a collagen model fluorescence resonance energy transfer substrate.

Authors:  Janelle L Lauer-Fields; Timothy P Spicer; Peter S Chase; Mare Cudic; Gayle D Burstein; Hideaki Nagase; Peter Hodder; Gregg B Fields
Journal:  Anal Biochem       Date:  2007-09-15       Impact factor: 3.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.